NEW YORK, NY / ACCESSWIRE / June 26, 2017 / Fitbit saw a slight gain in Friday trading while shares of Groupon experienced a big breakout closing the day up over 8%. Fitbit is now tackling the $4.6 billion sleep apnea market and considering how much the stock has dropped in the last year, traders are anxious for the company to score a home run on it. Groupon didn't have any remarkable news this past Friday to explain the gains, but considering shares had been slipping since the company released its first quarter earnings report last month, they were pretty encouraging to see.

RDI Initiates Coverage on:

Fitbit, Inc.
https://ub.rdinvesting.com/news/?ticker=FIT

Groupon, Inc.
https://ub.rdinvesting.com/news/?ticker=GRPN

Fitbit, Inc.'s shares closed up a modest 1.38% this past Friday on heavy trading volume. The wearable tracking company has had a rough year with a share price drop of over 55%. The company is now focused on a large market that could help it turnaround. Apparently Fitbit told CNBC that it is now building tools that can help diagnose and monitor sleep apnea. Sleep apnea is a disorder in which breathing repeatedly stops and starts. The company's lead research scientist Connor Henehan stated, "We'd perform a useful public service by alerting users to the fact that they have a problem." Many people with sleep apnea don't even know that they have it. Earlier this month the company also announced a three-year deal with the NBA's Minnesota Timberwolves to be the "official wearable" and "official sleep tracker" of the team.

Access RDI's Fitbit Research Report at:
https://ub.rdinvesting.com/news/?ticker=FIT

Groupon, Inc.'s shares closed up 8.10% on Friday on trading volume roughly five times higher than usual. There was no significant news to explain the move up, but considering how much shares have fallen since the company's first quarter report, traders more than welcomed the gains. The daily deals company reported a loss of $0.02 in the first quarter 2017 which was better than the $0.05 loss that analysts had been expecting. The company's reported loss was also narrower than what analysts had looked for, at $0.04 per share compared to the $0.08 projected. Revenues at $673.6 million unfortunately missed the consensus estimate of $717.1 million. According to Marketbeat, the stock has a consensus rating of "Hold" on it from twenty one research firms. Analysts that have covered Groupon in the last year have an average twelve-month price target of $4.58 on it. Shares closed at $3.47 this past Friday.

Access RDI's Groupon Research Report at:
https://ub.rdinvesting.com/news/?ticker=GRPN

Our Actionable Research on Fitbit, Inc. (NYSE: FIT) and Groupon, Inc. (NASDAQ: GRPN) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com